0      0

2022 Annual Conference Posters

Non-CE Poster 8 - Efficacy and Safety of a Novel Gene Therapy (URO-902; pVAX/hSlo) in Female Patients With Overactive Bladder and Urge Urinary Incontinence: Results From a Phase 2a Trial


Speaker(s):

You must be logged in and own this session in order to post comments.